{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:05:58Z","timestamp":1762866358481},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Haemostatic management of surgery in patients with von Willebrand disease (VWD) includes DDAVP<jats:sup>\u00ae<\/jats:sup> or von Willebrand factor (VWF)\u2010containing concentrates. Although the recommendations are for monitoring by VWF activity assays, it is quite common for clinicians to use factor VIII due usually to longer turnaround times required for VWF ristocetin cofactor assay (VWF:RCo) measurements. The aim of this study was to evaluate use of the rapid HaemosIL<jats:sup>\u2122<\/jats:sup> VWF activity (VWF:Act) latex immuno assay (LIA) on an automated coagulometer (ACL TOP<jats:sup>\u2122<\/jats:sup> 700; Instrumentation Laboratory, Bedford, MA, USA) compared to platelet\u2010based VWF:RCo assays in this setting. One hundred and sixty\u2010seven plasma samples from 42 patients [Type 1 (<jats:italic>n<\/jats:italic>\u00a0=\u00a022), Type 2A (<jats:italic>n<\/jats:italic>\u00a0=\u00a02), Type 2B (<jats:italic>n<\/jats:italic>\u00a0=\u00a03), Type 2M (<jats:italic>n<\/jats:italic>\u00a0=\u00a010), Type 3 (<jats:italic>n<\/jats:italic>\u00a0=\u00a03)] and acquired von Willebrand syndrome (<jats:italic>n<\/jats:italic>\u00a0=\u00a02) with VWD treated with DDAVP<jats:sup>\u00ae<\/jats:sup> or VWF\u2010containing concentrates were included in the study. Method comparison and method bias were evaluated by Bland\u2013Altman analysis (BA) and Passing and Bablok regression modelling respectively. BA of baseline samples (<jats:italic>n<\/jats:italic>\u00a0=\u00a039) showed a mean difference of \u22123.0 (\u00b11.96 SD \u221225.2 to +19.4). Post (treatment) samples (<jats:italic>n<\/jats:italic>\u00a0=\u00a0120) were separated into two groups. Group 1 contained samples with VWF:RCo levels 10 to \u2264175\u00a0IU\u00a0dL<jats:sup>\u22121<\/jats:sup> (<jats:italic>n<\/jats:italic>\u00a0=\u00a097) and group 2, samples with VWF:RCo levels &gt;175\u00a0IU\u00a0dL<jats:sup>\u22121<\/jats:sup> (<jats:italic>n<\/jats:italic>\u00a0=\u00a023). BA of group 1 postsamples showed a mean difference of +3.4 (\u00b11.96 SD \u221244.6 to +51.5), and the BA of Group 2 samples was \u221223.9 (\u00b11.96 SD \u2212136.1 to +88.3). In conclusion, use of HaemosIL VWF:Act LIA test on an automated coagulometer is a reproducible and rapid assay that can be used as an alternative test for monitoring VWF replacement therapy, facilitating dose adjustments on a real\u2010time basis.<\/jats:p>","DOI":"10.1111\/hae.12437","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T10:32:40Z","timestamp":1398335560000},"source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of a rapid von Willebrand Factor Activity Latex Immuno Assay for monitoring of patients with von Willebrand disease (<scp>VWD<\/scp>) receiving <scp>DDAVP<\/scp><sup>\u00ae<\/sup> or <scp>VWF<\/scp> replacement therapy"],"prefix":"10.1111","volume":"20","author":[{"given":"S.","family":"Vinayagam","sequence":"first","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. R.","family":"Simons","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chowdary","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thurlow","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Riddell","sequence":"additional","affiliation":[{"name":"Katharine Dormandy Haemophilia Centre &amp; Thrombosis Unit Royal Free London NHS Foundation Trust London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60522-9"},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalance of von Willebrand's disease","volume":"69","author":"Rodeghiero F","year":"1987","journal-title":"Blood"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00886.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-947863"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000233365.10981.08"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029606291428"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610379848"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10766"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614162"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200408000-00011"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03199.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/096228029900800204"},{"key":"e_1_2_7_14_1","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I","volume":"21","author":"Passing H","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3283254570"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01049.x"},{"issue":"2","key":"e_1_2_7_18_1","first-page":"33","article-title":"Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage","volume":"6","author":"Franchini M","year":"2008","journal-title":"Blood Transfus"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000214857"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02441.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0631"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02588.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02534.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2008.10.008"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1160\/TH07-08-0527","article-title":"PFA\u2010100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII\/VWF concentrate substitution in von Willebrand disease type 1 and 2","volume":"100","author":"Vliet HH","year":"2008","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610379848"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04460.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-299016"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12203"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhae.12437","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.12437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:07:42Z","timestamp":1695571662000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.12437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1111\/hae.12437"],"URL":"https:\/\/doi.org\/10.1111\/hae.12437","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}